NCT03719131 2025-04-22Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab TherapyEmory UniversityPhase 2 Active not recruiting15 enrolled 10 charts
NCT01307267 2020-03-17A Study Of PF-05082566 As A Single Agent And In Combination With RituximabPfizerPhase 1 Completed190 enrolled 65 charts